Blog Read the latest perspectives from our team of subject matter experts and others Redefining Medical Affairs Strategy with DataAs the role of Medical Affairs continues to evolve, data plays an increasingly critical role in shaping key opinion leader (KOL) engagement strategies, identifying care gaps, and ensuring equitable… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Drug Development Global Impact HCP Volunteers KOL Engagement Patient Representation Provider Data Research Post Industries:Commercialization Global Impact Health Plans & Digital Health Pharmaceutical & Biotechnology Provider Data Research ResearchThe COVID-19 Essential Reading CollectionThe next collection in our series of Faculty Opinions Essential Reading that we want to highlight is COVID-19. When the COVID-19 pandemic arrived, it disrupted nearly every aspect of our… Continue reading → Read the article Patient RepresentationHow to Build a Scalable Diversity StrategyPut simply – in 2022, clinical trial diversity, equity and inclusion (DEI) was top of mind for the pharma and biotech industries, across all phases of drug and device… Continue reading → Read the articleno ResearchResearch Collection: Alzheimer’s DiseaseWe’re delighted to launch the second Faculty Opinions Essential Reading collection: Alzheimer’s. Millions of people worldwide live with dementia, including Alzheimer’s. Our Faculty finds and assesses the literature to highlight the… Continue reading → Read the article KOL EngagementTis the Season…for Conference PlanningAs we come out of the holidays , in the United States, some of the greatest minds in medicine and healthcare are gathered this week at the JP Morgan Healthcare… Continue reading → Read the articleno ResearchResearch Collection: Opioid AddictionWe’re delighted to launch the fourth Faculty Opinions Essential Reading collection: Opioid Addiction. “Opioid abuse and addiction are major global health issues today. This collection aims to collate notable research… Continue reading → Read the articleno Drug DevelopmentPatient RepresentationThree Essential Data Insights for Optimal Trial Site Feasibility, Inclusivity and SelectionWhen you google the term “clinical trial,” the first thing that comes up is the National Library of Medicine site all about clinical research. It’s a great foray and… Continue reading → Read the articleno«‹567891011›»
